Torrent Pharmaceuticals has reignited negotiations to acquire private equity firm KKR’s 47.8% controlling stake in J.B. Chemicals & Pharmaceuticals. This move comes nearly 10 months after initial talks stalled. The proposed deal is valued at approximately $2.4 billion, and Torrent is reportedly preparing to arrange around $1.6 billion in financing to support the acquisition . If successful, this deal would mark a significant expansion of Torrent’s footprint in India’s pharmaceutical market, enhancing both scale and capabilities.

sources